Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
Market News
NTLA
EDIT
From
InvestorPlace
EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock
October 18, 2021
Tickers
NTLA
Tags
Benzinga
Trading Ideas
NTLA
From
Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
Tickers
ARKG
ARKK
BEAM
CRSP
Tags
NTLA
ARKK
VERV
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
NTLA
Market News
CRSP
From
Motley Fool
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
October 15, 2021
Tickers
BLFS
EDIT
LZAGF
MRNA
Tags
BLFS
MRNA
EDIT
From
Motley Fool
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
Tickers
ALNY
CELH
GOOG
GOOGL
Tags
NTLA
Market News
VIR
From
Motley Fool
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
Tickers
ATRA
CRSP
CTSO
FIXX
Tags
General
Earnings
RGLS
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
Tickers
CRSP
MRK
NTLA
REGN
Tags
VRTX
TAK
NTLA
From
Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Tickers
AGRX
ALLO
CCXI
CLLS
Tags
CCXI
CLLS
ORIC
From
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Tickers
ABIO
ADVM
AFIB
AGRX
Tags
CALT
GLTO
ALLO
From
Benzinga
3 Spooky Healthcare Stocks I Would Avoid in October
October 07, 2021
Tickers
BKD
EDIT
JNJ
MRNA
Tags
NVAX
PFE
BKD
From
Motley Fool
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
October 06, 2021
Tickers
NTLA
Tags
Briefs
News
General
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Tickers
AC
ACA
ACI
ADDYY
Tags
ADDYY
EQIX
FB
From
Benzinga
3 Most Overvalued Biotech Stocks on the Market Right Now
October 01, 2021
Tickers
BEAM
BNTX
CRSP
CVAC
Tags
CVAC
MRNA
BNTX
From
Motley Fool
Why Shares of Editas Medicine Are Lower This Morning
September 29, 2021
Tickers
EDIT
NTLA
REGN
Tags
EDIT
NTLA
Market News
From
Motley Fool
Breaking Down CRISPR Technology
September 28, 2021
Tickers
BEAM
CRBU
CRSP
EDIT
Tags
NTLA
Market News
VRTX
From
Motley Fool
Where Intellia Therapeutics Stands With Analysts
September 24, 2021
Tickers
NTLA
Tags
Benzinga
BZI/AAR
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
Tickers
ACHC
AEM
ALLO
ALV
Tags
HUMA
SLG
BJRI
From
Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
Tickers
ARKG
ARKK
BEAM
CLLS
Tags
ARKK
EDIT
CRBU
From
Motley Fool
3 Moonshot Stocks Hidden in Cathie Wood’s Portfolios
September 22, 2021
Tickers
AMZN
ARKK
CNDT
COIN
Tags
MSFT
TSP
Market Insight, Financial Articles
From
InvestorPlace
Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
September 16, 2021
Tickers
NTLA
Tags
acute myeloid leukemia
cancer
General
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
Tickers
ACER
ACRS
AERI
CRVS
Tags
LPTX
BZI/TFM
Top Gainers
From
Benzinga
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
Tickers
BAC
BEAM
BLUE
CLLS
Tags
EDIT
BLUE
Hot Stocks
From
InvestorPlace
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
Tickers
AZN
BIIB
CRSP
DHR
Tags
VRTX
NTLA
Market News
From
Motley Fool
3 Hot Stocks to Buy in September
September 07, 2021
Tickers
DOCU
MDB
NTLA
REGN
Tags
MDB
REGN
SNY
From
Motley Fool
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
Tickers
BEAM
EDIT
ILMN
NTLA
Tags
NASDAQ:ILMN,NASDAQ:BEAM,NASDAQ:EDIT,NASDAQ:NTLA
Hot Stocks
BEAM
From
InvestorPlace
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
Tickers
BEAM
EDIT
ILMN
NTLA
Tags
NASDAQ:ILMN,NASDAQ:BEAM,NASDAQ:EDIT,NASDAQ:NTLA
Hot Stocks
BEAM
From
InvestorPlace
Gene Editing Stocks: The Trial News Lifting NTLA, CRSP and EDIT Stocks Today
August 23, 2021
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
EDIT
Today's Market
From
InvestorPlace
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
August 12, 2021
Tickers
CRSP
EDIT
MRNA
NTLA
Tags
NTLA
MRNA
EDIT
From
Motley Fool
Intellia Therapeutics, inc (NTLA) Q2 2021 Earnings Call Transcript
August 06, 2021
Tickers
NTLA
Tags
NTLA
Market News
From
Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.